Recombinant Antibodies for Research

Award Winning Innovation

The ZooMAb^® recombinant monoclonal antibody platform was awarded the "2020 Innovative Product of the Year" by CiteAb, a leading life science data provider for citations and market data. We continue to push boundaries to help you make your next big discovery, vial after vial.

• Read more about what makes ZooMAb^® antibodies stand out in CiteAb’s award release.
• Discover more about how we are continuing to innovate with ZooMAb^® antibodies in this CiteAb interview.

• Preservative-free

  Every ZooMAb^® antibody is provided free of biocides like sodium azide or preservatives of animal origin, such as bovine serum albumin (BSA), and finished in a simple phosphate buffered saline (PBS) with trehalose. With ZooMAb^® antibodies, complications arising from potentially hazardous materials or local safety restrictions are minimized and allow its use in both in vivo and in vitro applications.

• Animal-free

  Every ZooMAb^® antibody is produced without the harm or sacrifice of animals. The proprietary recombinant expression system eliminates the need for arduous cell fusion and hybridoma construction, while providing greater specificity, affinity and reproducibility than monoclonal counterparts.

• Multiple Pack Sizes for Your Specific Need

  Every ZooMAb^® antibody is pre-aliquoted at 25 µL lyophilized equivalents to maximize product shelf life. Hence, you only purchase what you need and resuspend what you will use for your research.

• Consistency for Each Application

  ZooMAb^® antibodies are recombinantly produced, purified and pre-aliquoted for you. Every antibody is tested in our own laboratory to work in at least 3 applications and ensured to perform the way you would expect it to in Western blotting, immunofluorescence, and other common applications.

ZooMAb^® Antibodies Validation

Proper antibody validation is essential for accurate and reproducible results and is helpful in avoiding unreliable results and reducing research efforts. To ensure their specificity and performance the majority of ZooMAb^® antibodies are tested in a minimum of three applications. This includes assessing their binding characteristics and evaluating their performance in multiple assays, which is essential for determining their consistent performance across different experimental conditions.  

Validation Data for Anti-OCT4, Clone 4N8 ZooMAb^® Rabbit Monoclonal Antibody. 

ZooMAb^® Recombinant Antibodies Offer Lot-to-Lot Consistency

ZooMAb^® recombinant antibodies are manufactured by cloning antibody genes into expression vectors, which are subsequently introduced into expression hosts to provide animal-free antibody production. It avoids any sequence mutations and ensures high lot-to-lot consistency, which is also rigorously quality tested in multiple applications. We aim to support researchers in obtaining reliable, reproducible results and even offer an antibody guarantee.

Don’t See What You Need?

We offer contract ZooMAb^® antibody development services to generate antibodies for your desired targets and applications. Take advantage of our extensive expertise in immunogen design and preparation, antibody development and screening, application-specific testing, and antibody manufacturing at the scale that is relevant to your goals.

For Research Use Only. Not for use in diagnostic procedures.

Unless otherwise stated in the Product(s) specifications, any Antibody product is sold for internal research use only and may not be used for any other purpose, which includes but is not limited to, any commercial, diagnostic, or therapeutic use. Our validation processes pertain only to research uses and do not confirm or assure that our antibodies can be used for any unauthorized uses as set forth herein.